IMW 2019 | DNA methyltransferase inhibitors: daratumumab enhancement for MM

Priya Choudhry, PhD, from the University of California, San Francisco, CA, discusses how the use of DNA methyltransferase inhibitors upregulate CD38 expression and enhance daratumumab efficacy at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.